Overview

Double-masked Study of Netarsudil (AR-13324) Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
To evaluate ocular hypotensive efficacy and safety of Netarsudil (AR-13324) Ophthalmic Solution compared to Timolol Maleate Ophthalmic Solution.
Phase:
Phase 3
Details
Lead Sponsor:
Aerie Pharmaceuticals
Treatments:
Maleic acid
Ophthalmic Solutions
Pharmaceutical Solutions
Timolol